dm+d
108698001
Medicine Compliance Aid Stability
Epivir
ViiV Healthcare UK Ltd
ViiV Healthcare UK Ltd
Epivir
Tablets 150mg, 300mg
A3 · Amber 3 No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Airtight container and protect from light.
12 October 2022
Lactation Safety Information
For HIV infection
For HIV infection
Specialist drug/complex disease area for which expert advice is recommended
18 September 2020
For viral hepatitis
For viral hepatitis
Tenofovir
No adverse effects reported in breastfed infants
Small amounts in breast milk
For hepatitis B infection
Moderate level of evidence of use in breastfeeding
18 September 2020